Le Lézard
Classified in: Science and technology, Sports and recreation
Subject: PDT

DNA Dynamics, Inc. Updates Shareholders on Sports Gambling Strategy


NEW YORK, June 5, 2018 /PRNewswire/ -- DNA Dynamics, Inc. (USOTC: DNAD) announces today that it has refreshed its website to help shareholders get clearer information on the direction of the company and its strategy surrounding the new Sports Gambling Platform that it has under development.

Carl Grant, DNA's CEO, told shareholders that "over the coming weeks we are going to make real strides towards better quality information dissemination to shareholders. To that end, we unveiled a website refresh with some 'teasers' about the Sports Gambling Platform that is already in development."

He continues, "As we go through the development process we will be offering shareholders and interested parties the ability to download more strategic documents and examples of how the platform is taking shape.  We won't be unveiling the final branding until launch, but 'Project Accumulate', as we are calling it, is really taking shape and I look forward to sharing information with you as we sign new partners, develop new artwork and refine our 'Go To Market' strategy."

About DNA Dynamics, Inc.

Headquartered in Grandville Michigan and with operations in the UK, DNA Dynamics' business focuses on 'Mobile Gaming' and is building a diverse portfolio of assets. For more information contact (616) 552-9653 or email [email protected]

Forward-Looking Statements

This press release may contain forward-looking statements, including information about management's view of DNA Dynamics, Inc.'s future expectations, plans and prospects. In particular, when used in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of DNA Dynamics, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on DNA Dynamics' future results. The forward-looking statements included in this press release are made only as of the date hereof. DNA Dynamics cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, DNA Dynamics undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by DNA Dynamics.

 

SOURCE DNA Dynamics, Inc.


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The Industrial Technology Research Institute (ITRI) convened the 2024 ITRI Net Zero Day in Taipei, accelerating industry's transition to net-zero emissions. The event highlighted key innovations and successful business cases, focusing on the...

25 avr 2024
The report titled "Identity Governance & Administration Market by Component (Services, Solution), Modules (Access Certification & Compliance Control, Access Management, Identity Lifecycle Management), Organization Size, Deployment, Vertical - Global...

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Bristow Group Inc. , the global leader in innovative and sustainable vertical flight solutions, today announced it will release its first quarter 2024 financial results and selected financial outlook for 2025 and 2026 after market close on Tuesday,...

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: